During the past decade, Division of Cardiology, Peking University First Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Cardiology, Peking University First Hospital" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Chinese Medical Doctor Association" with 1 trials as a collaborator, "Philips Electronics Nederland B.V. acting through Philips CTO organization" with 1 trials as a collaborator and "Rainmed Ltd., Suzhou, China" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Division of Cardiology, Peking University First Hospital" are "Coronary Artery Disease" (2 trials), "Non-ST Segment Elevation Myocardial Infarction" (2 trials), "ST Segment Elevation Myocardial Infarction" (2 trials), "Stable Angina Pectoris" (2 trials) and "Unstable Angina Pectoris" (2 trials). Many other conditions were trialed in "Division of Cardiology, Peking University First Hospital" in a lesser frequency.

Most popular intervention types in "Division of Cardiology, Peking University First Hospital" are "Drug" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin" (1 trials), "BAMA solution" (1 trials), "FFR" (1 trials), "Nifedipine GITS" (1 trials) and "Rosuvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Cardiology, Peking University First Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Division of Cardiology, Peking University First Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Division of Cardiology, Peking University First Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Division of Cardiology, Peking University First Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".